阅读说明：本技术 作为治疗新生性疾病的Bcl-2抑制剂的缩合杂环衍生物 (Condensed heterocyclic derivatives as Bcl-2 inhibitors for the treatment of neonatal diseases ) 是由 Y.陈 Y.娄 于 2018-08-22 设计创作，主要内容包括：本公开内容包括式(A)的化合物：<Image he="387" wi="700" file="DDA0002451631090000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>其中本文中限定R<Sub>1</Sub>、R<Sub>2</Sub>、R<Sub>3</Sub>、R<Sub>4</Sub>、R<Sub>5</Sub>、R<Sub>6</Sub>、R<Sub>7</Sub>、R<Sub>8</Sub>、R<Sub>9</Sub>、R<Sub>10</Sub>、R<Sub>11</Sub>和R<Sub>12</Sub>、j、k、m、n、Y、W、W<Sub>1</Sub>、W<Sub>2</Sub>、W<Sub>3</Sub>、V、L、Z<Sub>1</Sub>、Q<Sub>1</Sub>、Q<Sub>2</Sub>、Q<Sub>3</Sub>和Q<Sub>4</Sub>。还公开了使用这些化合物治疗新生性疾病、自身免疫性疾病或神经变性性疾病的方法。(In the present disclosureA compound comprising formula (A): wherein R is defined herein 1 、R 2 、R 3 、R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 And R 12 、j、k、m、n、Y、W、W 1 、W 2 、W 3 、V、L、Z 1 、Q 1 、Q 2 、Q 3 And Q 4 . Also disclosed are methods of using these compounds to treat neonatal, autoimmune or neurodegenerative diseases.)